MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 ...

Enzymes help speed up chemical reactions in the body. They control everything from digesting food, to muscle growth, to blood ...

Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent ...

The FDA has granted a de novo clearance to a new type of stent designed to hold open the passages down the windpipe and into ...

A spokesperson for federal prosecutors says former Abercrombie & Fitch CEO Michael Jeffries and two other men have been ...

Soda, chips, cookies—brands are turning the stuff we used to consider junk food into nutritionally awesome upgrades. Or so ...

At the GRx+Biosims 2024 conference, panelists explored challenges and progress in biosimilar interchangeability regulations ...

Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

FDA Commissioner Robert Califf criticized pharma companies on Monday for charging high prices for weight loss drugs. Califf ...

Bose gave up on Sleepbuds after two generations. It was a sad, premature end for a promising product. The headphone maker ...